马斯克Neuralink入局！联手顶尖学府攻关“智能仿生眼”

智通财经2025-07-26

马斯克创立的脑机植入公司Neuralink正与加州及西班牙的研究机构展开合作，共同推进一项视觉假体临床研究。这项由加州大学圣塔芭芭拉分校主导的试验，已于7月底在美国政府临床试验登记平台ClinicalTrials.gov上公示。据研究方案描述，该项目旨在“解决智能仿生眼研发中的关键科学问题”。研究人员表示，这款融合人工智能(AI)技术的设备将帮助视障人士实现人脸识别、户外导航及文字阅读等功能。目前...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2554790132?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/0eb98587b5c81b2fc132df8572df3306","is_english":false,"pubTime":"2025-07-26 10:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2554790132","market":"sh","top_or_hot":-1,"title":"马斯克Neuralink入局！联手顶尖学府攻关“智能仿生眼”","media":"智通财经","content":"<div>\n<p>马斯克创立的脑机植入公司Neuralink正与加州及西班牙的研究机构展开合作，共同推进一项视觉假体临床研究。这项由加州大学圣塔芭芭拉分校主导的试验，已于7月底在美国政府临床试验登记平台ClinicalTrials.gov上公示。据研究方案描述，该项目旨在“解决智能仿生眼研发中的关键科学问题”。研究人员表示，这款融合人工智能(AI)技术的设备将帮助视障人士实现人脸识别、户外导航及文字阅读等功能。目前...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1322262.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>马斯克Neuralink入局！联手顶尖学府攻关“智能仿生眼”</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n马斯克Neuralink入局！联手顶尖学府攻关“智能仿生眼”\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-26 10:41 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1322262.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>马斯克创立的脑机植入公司Neuralink正与加州及西班牙的研究机构展开合作，共同推进一项视觉假体临床研究。这项由加州大学圣塔芭芭拉分校主导的试验，已于7月底在美国政府临床试验登记平台ClinicalTrials.gov上公示。据研究方案描述，该项目旨在“解决智能仿生眼研发中的关键科学问题”。研究人员表示，这款融合人工智能(AI)技术的设备将帮助视障人士实现人脸识别、户外导航及文字阅读等功能。目前...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1322262.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0097036916.USD","symbol_name":"贝莱德美国增长A2 USD","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1322262.html","article_id":"2554790132","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/0eb98587b5c81b2fc132df8572df3306"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2554790132","pubTimestamp":1753497660,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"马斯克创立的脑机植入公司Neuralink正与加州及西班牙的研究机构展开合作，共同推进一项视觉假体临床研究。目前Neuralink在试验中的具体角色尚未明确。研究说明中提到，将“在条件成熟时”引入Neuralink的患者数据。截至发稿，加州大学圣塔芭芭拉分校与Neuralink均未回应置评请求。据了解，Neuralink正在开发的“盲视”脑机芯片技术，不仅致力于帮助盲人重获光明，更计划赋予使用者超越常人的视觉能力。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0097036916.USD":"贝莱德美国增长A2 USD","BK4511":"特斯拉概念","BK4585":"ETF&股票定投概念","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","LU2471134523.USD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (USD) ACC","LU1852331112.SGD":"Blackrock World Technology Fund A2 SGD-H","BK4555":"新能源车","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","LU2250418816.HKD":"BGF WORLD TECHNOLOGY \"A\" (HKD) ACC","LU1778281490.HKD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (HKD) INC","LU0345769631.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) INC","LU2108987350.USD":"UBS (LUX) EQUITY SICAV GLOBAL OPPORTUNITY SUSTAINABLE (USD) \"P\" (USD) ACC","BK4516":"特朗普概念","LU2063271972.USD":"富兰克林创新领域基金","BK4592":"伊斯兰概念","LU2602419157.SGD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"AC\" (SGD) ACC","LU0082616367.USD":"摩根大通美国科技A（dist）","LU2360107168.USD":"BGF NEXT GENERATION TECHNOLOGY \"A4\" (USD) INC","SG9999015986.USD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (USD) ACC","LU0077335932.USD":"FIDELITY AMERICAN GROWTH \"A\" INC","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","LU2290526834.HKD":"BGF NEXT GENERATION TECHNOLOGY \"A2\" (HKDHDG) ACC","LU1145028129.USD":"ALLIANZ INCOME AND GROWTH \"AQ\" (USD) INC","LU1232071149.USD":"AZ FUND 1 GLOBAL GROWTH SELECTOR \"AAZ\" (USDHDG) ACC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","LU2023250330.USD":"ALLIANZ INCOME AND GROWTH \"AMG\" (USD) INC","BK4548":"巴美列捷福持仓","IE00BK4W5M84.HKD":"HSBC GLOBAL FUNDS ICAV US EQUITY INDEX \"HC\" (HKD) ACC","IE00BJLML261.HKD":"HSBC GLOBAL EQUITY INDEX \"HCH\" (HKD) ACC","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","LU2249611893.SGD":"BNP PARIBAS ENERGY TRANSITION \"CRH\" (SGD) ACC","BK4598":"佩洛西持仓","LU1674673428.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AC\" (USD) ACC","TSYW.SI":"TESLA 3xLongSG261006","LU1429558221.USD":"Natixis Loomis Sayles US Growth Equity RA USD","LU1548497426.USD":"安联环球人工智能AT Acc","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","LU1839511570.USD":"WELLS FARGO GLOBAL FACTOR ENHANCED EQUITY \"I\" (USD) ACC","LU1861220033.SGD":"Blackrock Next Generation Technology A2 SGD-H","LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","DXYZ":"Destiny Tech100 Inc","BK4604":"机器人概念","LU0823411888.USD":"法巴消费创新基金 Cap","TSLA":"特斯拉","IE00BK4W5L77.USD":"HSBC GLOBAL FUNDS ICAV US EQUITY INDEX \"HC\" (USD) ACC","LU2471134952.CNY":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (CNYHDG) INC","LU1435385759.SGD":"Natixis Loomis Sayles US Growth Equity RA SGD-H","BK4543":"AI","LU2471134879.HKD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (HKD) INC"},"translate_title":"Musk Neuralink enters the game! Join hands with top universities to tackle key problems in \"intelligent bionic eye\"","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/107f1ee32eeff33d1f6b329e32e7d030","symbols_score_info":{"DXYZ":1,"TSYW.SI":0.6,"TSLA":1},"content_text":"马斯克创立的脑机植入公司Neuralink正与加州及西班牙的研究机构展开合作，共同推进一项视觉假体临床研究。这项由加州大学圣塔芭芭拉分校主导的试验，已于7月底在美国政府临床试验登记平台ClinicalTrials.gov上公示。据研究方案描述，该项目旨在“解决智能仿生眼研发中的关键科学问题”。研究人员表示，这款融合人工智能(AI)技术的设备将帮助视障人士实现人脸识别、户外导航及文字阅读等功能。目前Neuralink在试验中的具体角色尚未明确。研究说明中提到，将“在条件成熟时”引入Neuralink的患者数据。根据公示信息，该试验现阶段仅通过邀请方式招募受试者。截至发稿，加州大学圣塔芭芭拉分校与Neuralink均未回应置评请求。据了解，Neuralink正在开发的“盲视”(Blindsight)脑机芯片技术，不仅致力于帮助盲人重获光明，更计划赋予使用者超越常人的视觉能力。该技术已完成灵长类动物实验，但尚未开展人体临床试验。报道指出，马斯克的公司计划在2030年前实现“盲视”技术的商业化应用。到2031年，该公司期望通过至少三种不同类型的脑机植入设备，实现年营收10亿美元的业绩目标。","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2554790132","isCrawlerRequest":true}